NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Medicine & Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine & Law Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Aarhus University, Denmark



Research from Denmark, Switzerland and Brazil in diabetes provides new insights



October 13th, 2006

Reports from Denmark, Switzerland and Brazil highlight recent research in diabetes.

Study 1: Systolic left ventricular function was linked to metabolic control and left ventricular mass in hypertensive patients with type 2 diabetes.

According to recent research from Denmark, "Decreased left ventricular long-axis function may be the earliest stage in subclinical heart failure in type 2 diabetes. To assess whether a decrease in SBP (systolic blood pressure) or a change in metabolic control would improve the long-axis function, 48 type 2 diabetic patients participating in the CALM II (Candesartan and Lisinopril Microalbuminuria II) study were included...


Source: Medicine & Law Weekly (2006-10-13)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login